Institutional members access full text with Ovid®

Share this article on:

HIV epidemics among transgender women

Poteat, Toniaa; Reisner, Sari L.b,c; Radix, Anitad

Current Opinion in HIV and AIDS: March 2014 - Volume 9 - Issue 2 - p 168–173
doi: 10.1097/COH.0000000000000030
EPIDEMIOLOGY: CONCENTRATED EPIDEMICS: Edited by Chris Beyrer, Stefan D. Baral, and Patrick S. Sullivan

Purpose of review Recent data on the high burden of HIV among transgender women have stimulated interest in addressing HIV in this vulnerable population. This review situates the epidemiologic data on HIV among transgender women in the context of the social determinants of health and describes opportunities for effective interventions.

Recent findings Transgender women experience unique vulnerability to HIV that can be attributed to multilevel, intersecting factors that also influence the HIV treatment and care continuum. Stigma and discrimination, lack of social and legal recognition of their affirmed gender, and exclusion from employment and educational opportunities represent fundamental drivers of HIV risk in transgender women worldwide.

Summary Interventions to improve engagement in HIV prevention, testing, care, and treatment among transgender women should build on community strengths and address structural factors as well as psychosocial and biologic factors that increase HIV vulnerability and prevent access to HIV services.

aDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

bThe Fenway Institute, Fenway Health

cDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA

dCallen-Lorde Community Health Center, New York, New York, USA

Correspondence to Johns Hopkins School of Public Health, 615N. Wolfe Street, Room E7138, Baltimore, MD 21205, USA. Tel: +1 202 203 7490; e-mail:

Copyright © 2014 Wolters Kluwer Health, Inc. All rights reserved.